INFLIXIMAB-AXXQ

INFLIXIMAB-AXXQ was reported 117 times

These side effects are most commonly reported by patients taking INFLIXIMAB-AXXQ:

# Side effect Count
0 DRUG INEFFECTIVE 14
1 OFF LABEL USE 14
2 INFUSION RELATED REACTION 11
3 PAIN 11
4 RASH 9
5 URTICARIA 6
6 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6
7 ACCIDENTAL EXPOSURE TO PRODUCT 5
8 DYSPNOEA 5
9 ARTHRALGIA 4
10 CHEST DISCOMFORT 4
11 CROHN^S DISEASE 4
12 DIARRHOEA 4
13 FEELING ABNORMAL 4
14 ABDOMINAL PAIN UPPER 3
15 ADVERSE EVENT 3
16 ADVERSE REACTION 3
17 CONDITION AGGRAVATED 3
18 NAUSEA 3
19 PRURITUS 3
20 PSORIASIS 3
21 ANXIETY 2
22 AUTOIMMUNE HEPATITIS 2
23 COLITIS ULCERATIVE 2
24 CYTOMEGALOVIRUS COLITIS 2
25 DRUG EFFECT LESS THAN EXPECTED 2
26 ERYTHEMA 2
27 FATIGUE 2
28 FEELING HOT 2
29 MYALGIA 2
30 OCCUPATIONAL EXPOSURE TO PRODUCT 2
31 PARAESTHESIA 2
32 PNEUMONIA 2
33 RASH PRURITIC 2
34 REFUSAL OF TREATMENT BY PATIENT 2
35 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
36 VOMITING 2
37 WEIGHT INCREASED 2
38 ABDOMINAL PAIN 1
39 ABSCESS INTESTINAL 1
40 ACUTE HEPATIC FAILURE 1
41 ACUTE KIDNEY INJURY 1
42 ACUTE MYOCARDIAL INFARCTION 1
43 ADENOCARCINOMA OF COLON 1
44 ANAEMIA 1
45 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1
46 ANTIBODY TEST ABNORMAL 1
47 ATELECTASIS 1
48 BACK PAIN 1
49 BLOOD PRESSURE INCREASED 1
50 BONE ABSCESS 1
51 C-REACTIVE PROTEIN INCREASED 1
52 CHEST PAIN 1
53 CHILLS 1
54 CHOLESTASIS 1
55 COLITIS 1
56 CORONARY ARTERY OCCLUSION 1
57 CORONAVIRUS INFECTION 1
58 COVID-19 1
59 CYANOSIS 1
60 CYTOMEGALOVIRUS GASTROENTERITIS 1
61 DISEASE PROGRESSION 1
62 DIZZINESS 1
63 DRUG CLEARANCE INCREASED 1
64 DYSPHAGIA 1
65 ECZEMA 1
66 EXPIRED PRODUCT ADMINISTERED 1
67 EYE IRRITATION 1
68 FEAR 1
69 FLUSHING 1
70 FOOD ALLERGY 1
71 GASTRIC DISORDER 1
72 HEADACHE 1
73 HEPATIC STEATOSIS 1
74 HISTOPLASMOSIS DISSEMINATED 1
75 HYPERHIDROSIS 1
76 HYPERSENSITIVITY 1
77 HYPERTENSION 1
78 HYPOAESTHESIA 1
79 ILLNESS 1
80 IMMUNE SYSTEM DISORDER 1
81 INFUSION SITE WARMTH 1
82 INSURANCE ISSUE 1
83 IRON DEFICIENCY ANAEMIA 1
84 JOINT EFFUSION 1
85 JOINT SWELLING 1
86 LABORATORY TEST ABNORMAL 1
87 LARGE INTESTINE PERFORATION 1
88 LEFT VENTRICULAR FAILURE 1
89 LETHARGY 1
90 LEUKOPENIA 1
91 MALAISE 1
92 MENTAL IMPAIRMENT 1
93 METASTATIC NEOPLASM 1
94 MIGRAINE 1
95 MOUTH ULCERATION 1
96 MUCOSAL INFLAMMATION 1
97 MUSCULAR WEAKNESS 1
98 NASOPHARYNGITIS 1
99 OROPHARYNGEAL DISCOMFORT 1
100 OROPHARYNGEAL PAIN 1
101 OXYGEN SATURATION DECREASED 1
102 PALLOR 1
103 PALPITATIONS 1
104 PANIC ATTACK 1
105 PERIPHERAL SWELLING 1
106 PHARYNGEAL SWELLING 1
107 PHOTOPHOBIA 1
108 PLEURAL EFFUSION 1
109 PNEUMOPERITONEUM 1
110 PRODUCT DOSE OMISSION ISSUE 1
111 PRODUCT PREPARATION ERROR 1
112 PRODUCT PREPARATION ISSUE 1
113 PRODUCT STORAGE ERROR 1
114 PSORIATIC ARTHROPATHY 1
115 PYREXIA 1
116 RETINAL VASCULITIS 1
117 SARCOIDOSIS 1
118 SARS-COV-2 TEST POSITIVE 1
119 SEIZURE 1
120 SEROSITIS 1
121 SPEECH DISORDER 1
122 SWELLING 1
123 SWOLLEN TONGUE 1
124 THERAPEUTIC PRODUCT EFFECT DECREASED 1
125 THERAPEUTIC RESPONSE DECREASED 1
126 THERAPEUTIC RESPONSE DELAYED 1
127 THERAPY CESSATION 1
128 TRANSAMINASES INCREASED 1
129 TREMOR 1
130 TRYPTASE INCREASED 1
131 TUBERCULOSIS 1
132 URINARY TRACT INFECTION 1
133 VANISHING BILE DUCT SYNDROME 1
134 VISUAL IMPAIRMENT 1
135 WEIGHT DECREASED 1